REQUEST A DEMO
Total
USD $0.00
Search more companies

Rivbio Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Educational Services
Full name: Rivbio Sp. z o.o. Profile Updated: January 23, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Rivbio Sp. z o.o. is an enterprise located in Poland, with the main office in Wroclaw. The enterprise currently operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was established on December 29, 2022. There was a net sales revenue increase of 76.86% reported in Rivbio Sp. z o.o.’s latest financial highlights for 2025. During that time, Rivbio Sp. z o.o.’s total assets grew by 82.2%. In, 2025, the company’s net profit margin decreased by 3.72%.

Headquarters
Ul. Marsz. Jozefa Pilsudskiego 74/320
Wroclaw; Dolnoslaskie; Postal Code: 50-020

Contact Details: Purchase the Rivbio Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Rivbio Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Rivbio Sp. z o.o. report to view the information.
Incorporation Date:
December 29, 2022
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Rivbio Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
76.86%
Total Operating Revenue
76.86%
Operating Profit
51.05%
EBITDA
65.69%
Net Profit/Loss for the Period
50.9%
Total Assets
82.2%
Total Equity
76.36%
Operating Profit Margin
-3.7%
Net Profit Margin
-3.72%
Return on Equity (ROE)
-11.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?